From the Department of Medical Microbiology, Key Laboratory of Medical Molecular Virology of the Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032 and.
the College of Medical Technology, Zhejiang Chinese Medical University, Hangzhou 310053, China
J Biol Chem. 2018 Jan 26;293(4):1243-1258. doi: 10.1074/jbc.M117.804252. Epub 2017 Dec 1.
All reported α-l-fucosidases catalyze the removal of nonreducing terminal l-fucoses from oligosaccharides or their conjugates, while having no capacity to hydrolyze core fucoses in glycoproteins directly. Here, we identified an α-fucosidase from the bacterium with catalytic activity against core α-1,3-fucosylated substrates, and we named it core fucosidase I (cFase I). Using site-specific mutational analysis, we found that three acidic residues (Asp-242, Glu-302, and Glu-315) in the predicted active pocket are critical for cFase I activity, with Asp-242 and Glu-315 acting as a pair of classic nucleophile and acid/base residues and Glu-302 acting in an as yet undefined role. These findings suggest a catalytic mechanism for cFase I that is different from known α-fucosidase catalytic models. In summary, cFase I exhibits glycosidase activity that removes core α-1,3-fucoses from substrates, suggesting cFase I as a new tool for glycobiology, especially for studies of proteins with core fucosylation.
所有报道的α-L-岩藻糖苷酶都能催化从寡糖或其缀合物中去除非还原末端的岩藻糖,但没有能力直接水解糖蛋白中的核心岩藻糖。在这里,我们从细菌中鉴定出一种具有针对核心α-1,3-岩藻糖基化底物的催化活性的α-岩藻糖苷酶,并将其命名为核心岩藻糖苷酶 I(cFase I)。通过定点突变分析,我们发现预测的活性口袋中的三个酸性残基(Asp-242、Glu-302 和 Glu-315)对 cFase I 活性至关重要,其中 Asp-242 和 Glu-315 作为一对经典的亲核和酸碱残基,而 Glu-302 则起着尚未确定的作用。这些发现为 cFase I 的催化机制提供了一个不同于已知α-岩藻糖苷酶催化模型的解释。总之,cFase I 表现出糖苷酶活性,可从底物中去除核心α-1,3-岩藻糖,这表明 cFase I 是糖生物学的一种新工具,特别是对于具有核心岩藻糖基化的蛋白质的研究。